Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer.

Trial Profile

Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 May 2017

At a glance

  • Drugs Buparlisib (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Feb 2017 Status changed from active, no longer recruiting to discontinued.
    • 02 Jun 2015 Primary endpoint (Progression free survival) has not been met, according to abstract presented at ASCO 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top